OVALEAP sol inj 300 UI/0.5ml cartouche av 10 aigu

7680662550018 CH-66255 G03GA05 07.08.1.

Reimbursement limitations:

070810 NEU

N'est pas remboursé pour le traitement de l'obésité.

Remboursement uniquement après examen endocrinologique et …

OVALEAP sol inj 300 UI/0.5ml cartouche av 10 aigu
OVALEAP sol inj 300 UI/0.5ml cartouche av 10 aigu
OVALEAP sol inj 300 UI/0.5ml cartouche av 10 aigu
1 / 3
google

Details

Product number
6625501
CPT
-
Packaging group
1
Unit
Set
Composition
follitropinum alfa 300 U.I., natrii dihydrogenophosphas dihydricus, mannitolum, polysorbatum 20, antiox.: methioninum 250 µg, conserv.: alcohol benzylicus 5 mg, benzalkonii chloridum 10 µg, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.

Articles (1)

Ovaleap 300 IU/0.5 ml, solution injectable
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
26/02/2025
Professional SmPC
Français
26/02/2025
Professional SmPC
Italien
26/02/2025
Patient information leaflet
Allemand
01/02/2025
Patient information leaflet
Français
01/02/2025
Patient information leaflet
Italien
01/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 UI Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
250.0 UG Substance HIMDK
(N/A)
5.0 MG Substance Konservierungsstoff (Conservateur)
(N/A)
10.0 UG Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 116.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2018

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
66255
Drug name
Ovaleap, solution injectable
Galenic form
LSPA
ATC Code
G03GA05
Authorization status
Z
Dispensation category
A
First authorization
28/08/2018
Authorization expiration date
31/12/9999
IT number
07.08.1.
Domain
Human medicine
Field of application
Stimulierung der Follikelreifung bei anovulatorischen Zuständen, bei ärztlich assistierten Reproduktionsprogrammen und bei Frauen mit schwerem LH- und FSH-Mangel; Stimulierung der Spermatogenese

Packaging details

Description (FR)
OVALEAP sol inj 300 UI/0.5ml cartouche av 10 aigu
Description (DE)
OVALEAP Inj Lös 300 IE/0.5ml Patrone m 10 Nadeln
Market launch
28/08/2018
Narcotic (BTM)
No

Other packaging sizes

OVALEAP sol inj 450 UI/0.75ml cartouche av 10 aigu
1 SET
View
OVALEAP sol inj 900 UI/1.5ml cartouche av 20 aigu
1 SET
View